{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:18Z","timestamp":1793978838256,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62135003"],"award-info":[{"award-number":["62135003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022814","name":"Songshan Lake Materials Laboratory","doi-asserted-by":"publisher","award":["2023SLABFK12"],"award-info":[{"award-number":["2023SLABFK12"]}],"id":[{"id":"10.13039\/100022814","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119266","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:03:10Z","timestamp":1787922190000},"page":"119266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Scoring drug efficacy by integrating drug-induced protein-protein interactions into cellular phenotypic information"],"prefix":"10.1016","volume":"319","author":[{"given":"Lu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beini","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qialing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9036-6676","authenticated-orcid":false,"given":"Tongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119266_bib48","doi-asserted-by":"crossref","first-page":"D1266","DOI":"10.1093\/nar\/gkx965","article-title":"The BioStudies database\u2014one stop shop for all data supporting a life sciences study","volume":"46","author":"Sarkans","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119266_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1158\/2159-8290.CD-17-0268","article-title":"A road map for precision cancer medicine using personalized models","volume":"7","author":"Picco","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.119266_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrg3998","article-title":"Using human genetics to make new medicines","volume":"16","author":"Barrett","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejmech.2026.119266_bib3","first-page":"243","article-title":"Precision medicine-the golden gate for detection, treatment and prevention of Alzheimer's disease","volume":"3","author":"Hampel","year":"2016","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2026.119266_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1200\/JCO.19.03010","article-title":"Molecular landscape and actionable alterations in a genomically guided cancer clinical trial: national cancer institute molecular analysis for therapy choice (NCI-MATCH)","volume":"38","author":"Flaherty","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119266_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrc4015","article-title":"Precision medicine for cancer with next-generation functional diagnostics","volume":"15","author":"Friedman","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119266_bib6","first-page":"17","article-title":"Exploring the potential of drug response assays for precision medicine in ovarian cancer","volume":"22","author":"Singh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119266_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.blre.2015.12.002","article-title":"Targeted therapies for CLL: practical issues with the changing treatment paradigm","volume":"30","author":"Jain","year":"2016","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejmech.2026.119266_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-21-0410","article-title":"Implementing a functional precision medicine tumor board for acute myeloid leukemia","volume":"12","author":"Malani","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.119266_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.sbi.2024.102842","article-title":"Artificial intelligence for high content imaging in drug discovery","volume":"87","author":"Carreras-Puigvert","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119266_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nchembio.2360","article-title":"Global survey of the immunomodulatory potential of common drugs","volume":"13","author":"Vladimer","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119266_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119266_bib12","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.4389","article-title":"Functional precision cancer medicine-moving beyond pure genomics","volume":"23","author":"Letai","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119266_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fmed.2022.912641","article-title":"Functional drug screening in the era of precision medicine","volume":"9","author":"Napoli","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2026.119266_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/cdd.2009.123","article-title":"Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation","volume":"17","author":"D\u00fcssmann","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119266_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119266_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1017\/S1431927621013891","article-title":"Automated ExEm-spFRET microscope","volume":"28","author":"Sun","year":"2022","journal-title":"Microsc. Microanal."},{"key":"10.1016\/j.ejmech.2026.119266_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jemt.70056","article-title":"Non\u2010uniform illumination correction for quantitative fluorescence imaging","volume":"89","author":"Wang","year":"2026","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ejmech.2026.119266_bib18","article-title":"Controlling and online measurement of automatic dual-channel E-FRET microscope","volume":"53","author":"Zhang","year":"2019","journal-title":"Biomed. Signal Process Control"},{"key":"10.1016\/j.ejmech.2026.119266_bib19","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","article-title":"Cellpose 2.0: how to train your own model","volume":"19","author":"Pachitariu","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2026.119266_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1109\/TSMC.1979.4310076","article-title":"A threshold selection method from gray-level histograms","volume":"9","author":"Otsu","year":"2007","journal-title":"IEEE Trans. Syst. Man Cybern."},{"key":"10.1016\/j.ejmech.2026.119266_bib21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1109\/TPAMI.2006.172","article-title":"Subclass discriminant analysis","volume":"28","author":"Zhu","year":"2006","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"10.1016\/j.ejmech.2026.119266_bib22","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1098\/rspb.2012.1129","article-title":"Explaining differences in the lifespan and replicative capacity of cells: a general model and comparative analysis of vertebrates","volume":"279","author":"Gillooly","year":"2012","journal-title":"Proc. R. Soc. B-Biol. Sci."},{"key":"10.1016\/j.ejmech.2026.119266_bib23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0091270005278056","article-title":"Adverse drug reactions and avalanches: life at the edge of chaos","volume":"45","author":"Frattarelli","year":"2005","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119266_bib24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1593\/neo.05118","article-title":"Two-mechanism peak concentration model for cellular pharmacodynamics of doxorubicin","volume":"7","author":"El-Kareh","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejmech.2026.119266_bib25","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119266_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2019.05.001","article-title":"BCL-XL directly retrotranslocates the monomeric BAK","volume":"61","author":"Wang","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119266_bib27","doi-asserted-by":"crossref","first-page":"C51","DOI":"10.1152\/ajpcell.00287.2014","article-title":"Interaction between Na-K-ATPase and Bcl-2 proteins BclXL and bak","volume":"308","author":"Lauf","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ejmech.2026.119266_bib28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119266_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4143\/crt.2018.117","article-title":"Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib","volume":"51","author":"Kim","year":"2019","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.119266_bib30","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S1470-2045(17)30608-3","article-title":"Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial","volume":"18","author":"Wu","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2026.119266_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.119266_bib32","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jtho.2020.09.001","article-title":"Safety, efficacy, and pharmacokinetics of almonertinib (HS-10296) in pretreated patients with EGFR-mutated advanced NSCLC: a multicenter, open-label, phase 1 trial","volume":"15","author":"Yang","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ejmech.2026.119266_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pbio.2005970","article-title":"CellProfiler 3.0: next-generation image processing for biology","volume":"16","author":"McQuin","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2026.119266_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119266_bib35","series-title":"33rd SIBGRAPI Conference on Graphics, Patterns and Images (SIBGRAPI)","first-page":"340","article-title":"IEEE, from explanations to feature selection: assessing SHAP values as feature selection mechanism","author":"Marcilio","year":"2020"},{"key":"10.1016\/j.ejmech.2026.119266_bib36","doi-asserted-by":"crossref","first-page":"i246","DOI":"10.1093\/bioinformatics\/btq176","article-title":"Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework","volume":"26","author":"Yamanishi","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2026.119266_bib37","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","article-title":"AZD9291, an irreversible EGFR TKI, overcomes T790M-Mediated resistance to EGFR inhibitors in lung cancer","volume":"4","author":"Cross","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2026.119266_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41467-019-12928-6","article-title":"A Bayesian machine learning approach for drug target identification using diverse data types","volume":"10","author":"Madhukar","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119266_bib39","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3892\/mmr.2014.3058","article-title":"Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975\/gefinitib-resistant with epidermal growth factor receptor T790M mutation","volume":"11","author":"Zhao","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2026.119266_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/138945012802009017","article-title":"Vinorelbine in cancer therapy","volume":"13","author":"Capasso","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2026.119266_bib41","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1200\/JCO.21.02641","article-title":"AENEAS: a randomized phase III trial of aumolertinib versus gefitinib as first-line therapy for locally advanced or metastatic non-small-cell lung cancer with EGFR Exon 19 deletion or L858R mutations","volume":"40","author":"Lu","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119266_bib42","article-title":"Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data","volume":"3","author":"K\u00f6hn-Luque","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.ejmech.2026.119266_bib43","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1093\/nar\/29.18.3882","article-title":"Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells","volume":"29","author":"Bettinger","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119266_bib44","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s00018-019-03286-z","article-title":"Stoichiometry and regulation network of Bcl-2 family complexes quantified by live-cell FRET assay","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119266_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-016-0816-x","article-title":"Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity","volume":"14","author":"Roscilli","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119266_bib46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41597-023-02482-8","article-title":"Label-free tumor cells classification using deep learning and high-content imaging","volume":"10","author":"Piansaddhayanon","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejmech.2026.119266_bib47","doi-asserted-by":"crossref","first-page":"E2526","DOI":"10.1073\/pnas.1522612113","article-title":"NF-\u03baB\u2013driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance","volume":"113","author":"Chiu","year":"2016","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:59:55Z","timestamp":1793977195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S0223523426007117"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119266","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scoring drug efficacy by integrating drug-induced protein-protein interactions into cellular phenotypic information","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119266"}}